Life ScienceCompany
GlaxoSmithKline - Consumer Healthcare Portfolio Ownership
Who owns GlaxoSmithKline - Consumer Healthcare Portfolio?
GlaxoSmithKline - Consumer Healthcare Portfolio is owned by Crown Laboratories and Hildred Capital Partners. It was acquired on November 30, 2018.
Is GlaxoSmithKline - Consumer Healthcare Portfolio PE-backed?
Yes. GlaxoSmithKline - Consumer Healthcare Portfolio is owned by private equity investors Crown Laboratories and Hildred Capital Partners.
GlaxoSmithKline - Consumer Healthcare Portfolio Business Overview
Where is GlaxoSmithKline - Consumer Healthcare Portfolio headquartered?
GlaxoSmithKline - Consumer Healthcare Portfolio is headquartered in Brentford, United Kingdom.
What sector is GlaxoSmithKline - Consumer Healthcare Portfolio in?
GlaxoSmithKline - Consumer Healthcare Portfolio is a life science company.
Life Science M&A Summary in 2018
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.
Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.